1.
J Rheumatol
; 9(6): 932-4, 1982.
Article
in English
| MEDLINE
| ID: mdl-6819360
ABSTRACT
Treatment terminations with gold sodium thiomalate (GST) in 200 patients with rheumatoid arthritis (RA) were analyzed using the life table method. The termination rate was 27% at 6 months, 48% at 12 months and 84% at 48 months. The major reason for termination was mucocutaneous reaction. Pretreatment clinical and laboratory status of the RA did not influence terminations significantly. Concurrent administration of oral corticosteroids had no significant effect on gold terminations. Complete control of synovitis was achieved in 38% of patients by a median time of 6 months but sustained for greater than 12 months in only 19%.
Subject(s)
Arthritis, Rheumatoid/drug therapy , Gold Sodium Thiomalate/adverse effects , Adrenal Cortex Hormones/therapeutic use , Adult , Female , Gold Sodium Thiomalate/therapeutic use , Humans , Male , Risk , Time Factors
2.
J Rheumatol Suppl
; 8: 137-45, 1982.
Article
in English
| MEDLINE
| ID: mdl-6813475